Health Literacy As a Mediator Between Gender, Illness Identity, and Self-Efficacy (NCT06707116) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Health Literacy As a Mediator Between Gender, Illness Identity, and Self-Efficacy
100 participantsStarted 2025-01-01
Plain-language summary
The goal of this observational study is to understand the role of health literacy in shaping the relationship between gender differences, illness identity, and self-efficacy in geriatric patients with cardiac diseases. The main question it aims to answer is:
Does health literacy mediate the relationship between gender, illness identity, and self-efficacy in elderly cardiac patients?
Participants with diagnosed cardiac conditions, will complete online surveys assessing their health literacy, illness identity, and self-efficacy over a one-year period. Structural Equation Modeling (SEM) will be used to analyze the relationships among these variables.
Who can participate
Age range
30 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults aged 30 years or older.
* Diagnosed with a cardiac disease (e.g., heart failure, coronary artery disease, arrhythmia).
* Able to provide informed consent.
* Sufficient health literacy to complete surveys in the study language.
* Currently under regular medical care for their cardiac condition.
Exclusion Criteria:
* Individuals with a cognitive impairment or diagnosis of dementia that could interfere with survey participation.
* Patients with co-morbid terminal illnesses that significantly impact life expectancy (e.g., advanced cancer).
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Illness Identity Questionnaire (IIQ)
Timeframe: 1 month
Trial details
NCT IDNCT06707116
SponsorCairo University
Sponsor typeOTHER
Study typeOBSERVATIONAL
Primary completion2025-03-01
Contact for this trial
Mohammed ElSayed Zaky Principle Investigator, Ph.D